The pay plan, now valued at approximately $48 billion, had originally received 73% support six years ago but later annulled by a Delaware judge. The company did not immediately release the percentage of shareholders who voted for or against the compensation package.
Trending
- NAFDAC tightens pharmaceutical imports from China, India
- US tariffs a ‘significant risk’ to global economy—IMF Chief
- FG to adopt traceability technologies to boost agro-export value chain
- [EXPLAINER] All you need to know about goiter
- [EXPLAINER] Understanding popular myths and facts on ovulation
- Katsina govt to reactivate drug-resistant TB centre – Official
- Food prices drop in North-East
- Natasha Akpoti-Uduaghan: Freedom Fighter of the Decade, By Prof. Jibrin Ibrahim